nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilostazol—CYP1A2—Estropipate—osteoporosis	0.076	0.121	CbGbCtD
Cilostazol—CYP3A7—Estradiol—osteoporosis	0.0566	0.0901	CbGbCtD
Cilostazol—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.0566	0.0901	CbGbCtD
Cilostazol—CYP2C19—Cholecalciferol—osteoporosis	0.0425	0.0676	CbGbCtD
Cilostazol—CYP3A5—Estradiol—osteoporosis	0.0424	0.0676	CbGbCtD
Cilostazol—CYP3A4—Estropipate—osteoporosis	0.0398	0.0635	CbGbCtD
Cilostazol—CYP3A4—Calcitriol—osteoporosis	0.0398	0.0635	CbGbCtD
Cilostazol—CYP1A2—Conjugated Estrogens—osteoporosis	0.036	0.0573	CbGbCtD
Cilostazol—CYP2C19—Estradiol—osteoporosis	0.0342	0.0545	CbGbCtD
Cilostazol—CYP2D6—Cholecalciferol—osteoporosis	0.0323	0.0514	CbGbCtD
Cilostazol—CYP3A4—Ergocalciferol—osteoporosis	0.0319	0.0507	CbGbCtD
Cilostazol—CYP1A2—Estradiol—osteoporosis	0.0316	0.0503	CbGbCtD
Cilostazol—CYP3A4—Raloxifene—osteoporosis	0.0266	0.0423	CbGbCtD
Cilostazol—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0257	0.0409	CbGbCtD
Cilostazol—CYP3A4—Cholecalciferol—osteoporosis	0.0205	0.0327	CbGbCtD
Cilostazol—CYP3A4—Conjugated Estrogens—osteoporosis	0.0188	0.03	CbGbCtD
Cilostazol—CYP3A4—Estradiol—osteoporosis	0.0165	0.0264	CbGbCtD
Cilostazol—Haemoglobin—Estradiol—osteoporosis	0.000262	0.000727	CcSEcCtD
Cilostazol—Infection—Pamidronate—osteoporosis	0.000261	0.000726	CcSEcCtD
Cilostazol—Rhinitis—Estradiol—osteoporosis	0.000261	0.000726	CcSEcCtD
Cilostazol—Urticaria—Calcitriol—osteoporosis	0.000261	0.000725	CcSEcCtD
Cilostazol—Haemorrhage—Estradiol—osteoporosis	0.000261	0.000724	CcSEcCtD
Cilostazol—Palpitations—Zoledronate—osteoporosis	0.00026	0.000723	CcSEcCtD
Cilostazol—Abdominal pain—Calcitriol—osteoporosis	0.00026	0.000722	CcSEcCtD
Cilostazol—Body temperature increased—Calcitriol—osteoporosis	0.00026	0.000722	CcSEcCtD
Cilostazol—Hypoaesthesia—Estradiol—osteoporosis	0.000259	0.00072	CcSEcCtD
Cilostazol—Shock—Pamidronate—osteoporosis	0.000259	0.000719	CcSEcCtD
Cilostazol—Loss of consciousness—Zoledronate—osteoporosis	0.000259	0.000719	CcSEcCtD
Cilostazol—Pharyngitis—Estradiol—osteoporosis	0.000259	0.000718	CcSEcCtD
Cilostazol—Nervous system disorder—Pamidronate—osteoporosis	0.000258	0.000716	CcSEcCtD
Cilostazol—Thrombocytopenia—Pamidronate—osteoporosis	0.000258	0.000715	CcSEcCtD
Cilostazol—Vomiting—Etidronic acid—osteoporosis	0.000257	0.000715	CcSEcCtD
Cilostazol—Cough—Zoledronate—osteoporosis	0.000257	0.000713	CcSEcCtD
Cilostazol—Oedema peripheral—Estradiol—osteoporosis	0.000257	0.000713	CcSEcCtD
Cilostazol—Tachycardia—Pamidronate—osteoporosis	0.000257	0.000713	CcSEcCtD
Cilostazol—Rash—Etidronic acid—osteoporosis	0.000255	0.000709	CcSEcCtD
Cilostazol—Dermatitis—Etidronic acid—osteoporosis	0.000255	0.000708	CcSEcCtD
Cilostazol—Vertigo—Conjugated Estrogens—osteoporosis	0.000255	0.000707	CcSEcCtD
Cilostazol—Syncope—Conjugated Estrogens—osteoporosis	0.000254	0.000706	CcSEcCtD
Cilostazol—Hypertension—Zoledronate—osteoporosis	0.000254	0.000706	CcSEcCtD
Cilostazol—Headache—Etidronic acid—osteoporosis	0.000254	0.000704	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000252	0.0007	CcSEcCtD
Cilostazol—Asthenia—Estropipate—osteoporosis	0.000251	0.000698	CcSEcCtD
Cilostazol—Anorexia—Pamidronate—osteoporosis	0.000251	0.000696	CcSEcCtD
Cilostazol—Myalgia—Zoledronate—osteoporosis	0.000251	0.000696	CcSEcCtD
Cilostazol—Chest pain—Zoledronate—osteoporosis	0.000251	0.000696	CcSEcCtD
Cilostazol—Arthralgia—Zoledronate—osteoporosis	0.000251	0.000696	CcSEcCtD
Cilostazol—Palpitations—Conjugated Estrogens—osteoporosis	0.000251	0.000696	CcSEcCtD
Cilostazol—Insomnia—Risedronate—osteoporosis	0.00025	0.000695	CcSEcCtD
Cilostazol—Anxiety—Zoledronate—osteoporosis	0.00025	0.000694	CcSEcCtD
Cilostazol—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000249	0.000692	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000249	0.000691	CcSEcCtD
Cilostazol—Paraesthesia—Risedronate—osteoporosis	0.000248	0.00069	CcSEcCtD
Cilostazol—Pruritus—Estropipate—osteoporosis	0.000248	0.000688	CcSEcCtD
Cilostazol—Discomfort—Zoledronate—osteoporosis	0.000248	0.000688	CcSEcCtD
Cilostazol—Asthenia—Alendronate—osteoporosis	0.000247	0.000687	CcSEcCtD
Cilostazol—Cough—Conjugated Estrogens—osteoporosis	0.000247	0.000687	CcSEcCtD
Cilostazol—Dyspnoea—Risedronate—osteoporosis	0.000247	0.000685	CcSEcCtD
Cilostazol—Erythema multiforme—Estradiol—osteoporosis	0.000246	0.000684	CcSEcCtD
Cilostazol—Hypotension—Pamidronate—osteoporosis	0.000246	0.000683	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000245	0.00068	CcSEcCtD
Cilostazol—Pruritus—Alendronate—osteoporosis	0.000244	0.000678	CcSEcCtD
Cilostazol—Dyspepsia—Risedronate—osteoporosis	0.000244	0.000676	CcSEcCtD
Cilostazol—Tinnitus—Estradiol—osteoporosis	0.000243	0.000675	CcSEcCtD
Cilostazol—Cardiac disorder—Estradiol—osteoporosis	0.000242	0.000672	CcSEcCtD
Cilostazol—Arthralgia—Conjugated Estrogens—osteoporosis	0.000241	0.00067	CcSEcCtD
Cilostazol—Chest pain—Conjugated Estrogens—osteoporosis	0.000241	0.00067	CcSEcCtD
Cilostazol—Myalgia—Conjugated Estrogens—osteoporosis	0.000241	0.00067	CcSEcCtD
Cilostazol—Asthenia—Ibandronate—osteoporosis	0.000241	0.000669	CcSEcCtD
Cilostazol—Anxiety—Conjugated Estrogens—osteoporosis	0.000241	0.000668	CcSEcCtD
Cilostazol—Nausea—Etidronic acid—osteoporosis	0.00024	0.000668	CcSEcCtD
Cilostazol—Oedema—Zoledronate—osteoporosis	0.00024	0.000667	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.00024	0.000666	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.00024	0.000666	CcSEcCtD
Cilostazol—Diarrhoea—Estropipate—osteoporosis	0.00024	0.000665	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Risedronate—osteoporosis	0.000239	0.000663	CcSEcCtD
Cilostazol—Infection—Zoledronate—osteoporosis	0.000239	0.000663	CcSEcCtD
Cilostazol—Insomnia—Pamidronate—osteoporosis	0.000238	0.000661	CcSEcCtD
Cilostazol—Pruritus—Ibandronate—osteoporosis	0.000238	0.00066	CcSEcCtD
Cilostazol—Pain—Risedronate—osteoporosis	0.000237	0.000657	CcSEcCtD
Cilostazol—Angiopathy—Estradiol—osteoporosis	0.000236	0.000657	CcSEcCtD
Cilostazol—Shock—Zoledronate—osteoporosis	0.000236	0.000657	CcSEcCtD
Cilostazol—Paraesthesia—Pamidronate—osteoporosis	0.000236	0.000656	CcSEcCtD
Cilostazol—Diarrhoea—Alendronate—osteoporosis	0.000236	0.000655	CcSEcCtD
Cilostazol—Asthenia—Calcitriol—osteoporosis	0.000236	0.000655	CcSEcCtD
Cilostazol—Nervous system disorder—Zoledronate—osteoporosis	0.000236	0.000654	CcSEcCtD
Cilostazol—Thrombocytopenia—Zoledronate—osteoporosis	0.000235	0.000653	CcSEcCtD
Cilostazol—Mediastinal disorder—Estradiol—osteoporosis	0.000235	0.000652	CcSEcCtD
Cilostazol—Dyspnoea—Pamidronate—osteoporosis	0.000235	0.000651	CcSEcCtD
Cilostazol—Tachycardia—Zoledronate—osteoporosis	0.000235	0.000651	CcSEcCtD
Cilostazol—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000234	0.00065	CcSEcCtD
Cilostazol—Chills—Estradiol—osteoporosis	0.000234	0.000649	CcSEcCtD
Cilostazol—Skin disorder—Zoledronate—osteoporosis	0.000233	0.000648	CcSEcCtD
Cilostazol—Pruritus—Calcitriol—osteoporosis	0.000233	0.000646	CcSEcCtD
Cilostazol—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000232	0.000645	CcSEcCtD
Cilostazol—Diarrhoea—Raloxifene—osteoporosis	0.000232	0.000644	CcSEcCtD
Cilostazol—Dyspepsia—Pamidronate—osteoporosis	0.000232	0.000643	CcSEcCtD
Cilostazol—Dizziness—Estropipate—osteoporosis	0.000232	0.000643	CcSEcCtD
Cilostazol—Oedema—Conjugated Estrogens—osteoporosis	0.000231	0.000643	CcSEcCtD
Cilostazol—Infection—Conjugated Estrogens—osteoporosis	0.00023	0.000638	CcSEcCtD
Cilostazol—Diarrhoea—Ibandronate—osteoporosis	0.00023	0.000638	CcSEcCtD
Cilostazol—Anorexia—Zoledronate—osteoporosis	0.000229	0.000636	CcSEcCtD
Cilostazol—Decreased appetite—Pamidronate—osteoporosis	0.000229	0.000635	CcSEcCtD
Cilostazol—Dizziness—Alendronate—osteoporosis	0.000228	0.000633	CcSEcCtD
Cilostazol—Shock—Conjugated Estrogens—osteoporosis	0.000228	0.000632	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000227	0.000631	CcSEcCtD
Cilostazol—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000227	0.00063	CcSEcCtD
Cilostazol—Gastrointestinal pain—Risedronate—osteoporosis	0.000226	0.000628	CcSEcCtD
Cilostazol—Tachycardia—Conjugated Estrogens—osteoporosis	0.000226	0.000627	CcSEcCtD
Cilostazol—Urticaria—Ethinyl Estradiol—osteoporosis	0.000225	0.000626	CcSEcCtD
Cilostazol—Pain—Pamidronate—osteoporosis	0.000225	0.000625	CcSEcCtD
Cilostazol—Diarrhoea—Calcitriol—osteoporosis	0.000225	0.000625	CcSEcCtD
Cilostazol—Skin disorder—Conjugated Estrogens—osteoporosis	0.000225	0.000624	CcSEcCtD
Cilostazol—Hypotension—Zoledronate—osteoporosis	0.000225	0.000624	CcSEcCtD
Cilostazol—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000224	0.000623	CcSEcCtD
Cilostazol—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000224	0.000623	CcSEcCtD
Cilostazol—Dizziness—Raloxifene—osteoporosis	0.000224	0.000623	CcSEcCtD
Cilostazol—Flatulence—Estradiol—osteoporosis	0.000224	0.000621	CcSEcCtD
Cilostazol—Vomiting—Estropipate—osteoporosis	0.000223	0.000618	CcSEcCtD
Cilostazol—Dizziness—Ibandronate—osteoporosis	0.000222	0.000617	CcSEcCtD
Cilostazol—Rash—Estropipate—osteoporosis	0.000221	0.000613	CcSEcCtD
Cilostazol—Dermatitis—Estropipate—osteoporosis	0.000221	0.000613	CcSEcCtD
Cilostazol—Anorexia—Conjugated Estrogens—osteoporosis	0.000221	0.000612	CcSEcCtD
Cilostazol—Urticaria—Risedronate—osteoporosis	0.00022	0.000611	CcSEcCtD
Cilostazol—Back pain—Estradiol—osteoporosis	0.000219	0.000609	CcSEcCtD
Cilostazol—Headache—Estropipate—osteoporosis	0.000219	0.000609	CcSEcCtD
Cilostazol—Vomiting—Alendronate—osteoporosis	0.000219	0.000609	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000219	0.000608	CcSEcCtD
Cilostazol—Body temperature increased—Risedronate—osteoporosis	0.000219	0.000608	CcSEcCtD
Cilostazol—Abdominal pain—Risedronate—osteoporosis	0.000219	0.000608	CcSEcCtD
Cilostazol—Muscle spasms—Estradiol—osteoporosis	0.000218	0.000606	CcSEcCtD
Cilostazol—Rash—Alendronate—osteoporosis	0.000217	0.000604	CcSEcCtD
Cilostazol—Insomnia—Zoledronate—osteoporosis	0.000217	0.000604	CcSEcCtD
Cilostazol—Dermatitis—Alendronate—osteoporosis	0.000217	0.000603	CcSEcCtD
Cilostazol—Feeling abnormal—Pamidronate—osteoporosis	0.000217	0.000602	CcSEcCtD
Cilostazol—Hypotension—Conjugated Estrogens—osteoporosis	0.000216	0.0006	CcSEcCtD
Cilostazol—Headache—Alendronate—osteoporosis	0.000216	0.0006	CcSEcCtD
Cilostazol—Paraesthesia—Zoledronate—osteoporosis	0.000216	0.000599	CcSEcCtD
Cilostazol—Vomiting—Raloxifene—osteoporosis	0.000216	0.000599	CcSEcCtD
Cilostazol—Gastrointestinal pain—Pamidronate—osteoporosis	0.000215	0.000597	CcSEcCtD
Cilostazol—Dyspnoea—Zoledronate—osteoporosis	0.000214	0.000595	CcSEcCtD
Cilostazol—Rash—Raloxifene—osteoporosis	0.000214	0.000594	CcSEcCtD
Cilostazol—Dermatitis—Raloxifene—osteoporosis	0.000214	0.000593	CcSEcCtD
Cilostazol—Vomiting—Ibandronate—osteoporosis	0.000213	0.000593	CcSEcCtD
Cilostazol—Headache—Raloxifene—osteoporosis	0.000212	0.00059	CcSEcCtD
Cilostazol—Rash—Ibandronate—osteoporosis	0.000212	0.000588	CcSEcCtD
Cilostazol—Dermatitis—Ibandronate—osteoporosis	0.000212	0.000587	CcSEcCtD
Cilostazol—Dyspepsia—Zoledronate—osteoporosis	0.000212	0.000587	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000211	0.000585	CcSEcCtD
Cilostazol—Ill-defined disorder—Estradiol—osteoporosis	0.000211	0.000585	CcSEcCtD
Cilostazol—Headache—Ibandronate—osteoporosis	0.00021	0.000584	CcSEcCtD
Cilostazol—Insomnia—Conjugated Estrogens—osteoporosis	0.000209	0.000581	CcSEcCtD
Cilostazol—Vomiting—Calcitriol—osteoporosis	0.000209	0.00058	CcSEcCtD
Cilostazol—Decreased appetite—Zoledronate—osteoporosis	0.000209	0.00058	CcSEcCtD
Cilostazol—Nausea—Estropipate—osteoporosis	0.000208	0.000578	CcSEcCtD
Cilostazol—Abdominal pain—Pamidronate—osteoporosis	0.000208	0.000578	CcSEcCtD
Cilostazol—Body temperature increased—Pamidronate—osteoporosis	0.000208	0.000578	CcSEcCtD
Cilostazol—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000208	0.000577	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000207	0.000576	CcSEcCtD
Cilostazol—Rash—Calcitriol—osteoporosis	0.000207	0.000576	CcSEcCtD
Cilostazol—Dermatitis—Calcitriol—osteoporosis	0.000207	0.000575	CcSEcCtD
Cilostazol—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000206	0.000573	CcSEcCtD
Cilostazol—Headache—Calcitriol—osteoporosis	0.000206	0.000572	CcSEcCtD
Cilostazol—Pain—Zoledronate—osteoporosis	0.000205	0.000571	CcSEcCtD
Cilostazol—Nausea—Alendronate—osteoporosis	0.000205	0.000569	CcSEcCtD
Cilostazol—Malaise—Estradiol—osteoporosis	0.000205	0.000568	CcSEcCtD
Cilostazol—Vertigo—Estradiol—osteoporosis	0.000204	0.000566	CcSEcCtD
Cilostazol—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000204	0.000566	CcSEcCtD
Cilostazol—Asthenia—Ethinyl Estradiol—osteoporosis	0.000204	0.000566	CcSEcCtD
Cilostazol—Syncope—Estradiol—osteoporosis	0.000203	0.000565	CcSEcCtD
Cilostazol—Nausea—Raloxifene—osteoporosis	0.000201	0.000559	CcSEcCtD
Cilostazol—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000201	0.000559	CcSEcCtD
Cilostazol—Pruritus—Ethinyl Estradiol—osteoporosis	0.000201	0.000558	CcSEcCtD
Cilostazol—Palpitations—Estradiol—osteoporosis	0.0002	0.000557	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.0002	0.000555	CcSEcCtD
Cilostazol—Nausea—Ibandronate—osteoporosis	0.000199	0.000554	CcSEcCtD
Cilostazol—Loss of consciousness—Estradiol—osteoporosis	0.000199	0.000554	CcSEcCtD
Cilostazol—Asthenia—Risedronate—osteoporosis	0.000199	0.000551	CcSEcCtD
Cilostazol—Feeling abnormal—Zoledronate—osteoporosis	0.000198	0.00055	CcSEcCtD
Cilostazol—Cough—Estradiol—osteoporosis	0.000198	0.00055	CcSEcCtD
Cilostazol—Pain—Conjugated Estrogens—osteoporosis	0.000198	0.000549	CcSEcCtD
Cilostazol—Gastrointestinal pain—Zoledronate—osteoporosis	0.000196	0.000546	CcSEcCtD
Cilostazol—Hypertension—Estradiol—osteoporosis	0.000196	0.000544	CcSEcCtD
Cilostazol—Pruritus—Risedronate—osteoporosis	0.000196	0.000544	CcSEcCtD
Cilostazol—Nausea—Calcitriol—osteoporosis	0.000195	0.000542	CcSEcCtD
Cilostazol—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000194	0.000539	CcSEcCtD
Cilostazol—Arthralgia—Estradiol—osteoporosis	0.000193	0.000536	CcSEcCtD
Cilostazol—Chest pain—Estradiol—osteoporosis	0.000193	0.000536	CcSEcCtD
Cilostazol—Myalgia—Estradiol—osteoporosis	0.000193	0.000536	CcSEcCtD
Cilostazol—Anxiety—Estradiol—osteoporosis	0.000192	0.000535	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000192	0.000533	CcSEcCtD
Cilostazol—Urticaria—Zoledronate—osteoporosis	0.000191	0.00053	CcSEcCtD
Cilostazol—Discomfort—Estradiol—osteoporosis	0.000191	0.00053	CcSEcCtD
Cilostazol—Body temperature increased—Zoledronate—osteoporosis	0.00019	0.000528	CcSEcCtD
Cilostazol—Abdominal pain—Zoledronate—osteoporosis	0.00019	0.000528	CcSEcCtD
Cilostazol—Diarrhoea—Risedronate—osteoporosis	0.000189	0.000526	CcSEcCtD
Cilostazol—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000189	0.000525	CcSEcCtD
Cilostazol—Asthenia—Pamidronate—osteoporosis	0.000189	0.000524	CcSEcCtD
Cilostazol—Dizziness—Ethinyl Estradiol—osteoporosis	0.000188	0.000521	CcSEcCtD
Cilostazol—Pruritus—Pamidronate—osteoporosis	0.000186	0.000517	CcSEcCtD
Cilostazol—Oedema—Estradiol—osteoporosis	0.000185	0.000514	CcSEcCtD
Cilostazol—Infection—Estradiol—osteoporosis	0.000184	0.000511	CcSEcCtD
Cilostazol—Urticaria—Conjugated Estrogens—osteoporosis	0.000184	0.00051	CcSEcCtD
Cilostazol—Dizziness—Risedronate—osteoporosis	0.000183	0.000508	CcSEcCtD
Cilostazol—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000183	0.000508	CcSEcCtD
Cilostazol—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000183	0.000508	CcSEcCtD
Cilostazol—Shock—Estradiol—osteoporosis	0.000182	0.000506	CcSEcCtD
Cilostazol—Nervous system disorder—Estradiol—osteoporosis	0.000182	0.000504	CcSEcCtD
Cilostazol—Tachycardia—Estradiol—osteoporosis	0.000181	0.000502	CcSEcCtD
Cilostazol—Vomiting—Ethinyl Estradiol—osteoporosis	0.00018	0.000501	CcSEcCtD
Cilostazol—Diarrhoea—Pamidronate—osteoporosis	0.00018	0.0005	CcSEcCtD
Cilostazol—Skin disorder—Estradiol—osteoporosis	0.00018	0.000499	CcSEcCtD
Cilostazol—Rash—Ethinyl Estradiol—osteoporosis	0.000179	0.000497	CcSEcCtD
Cilostazol—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000179	0.000497	CcSEcCtD
Cilostazol—Headache—Ethinyl Estradiol—osteoporosis	0.000178	0.000494	CcSEcCtD
Cilostazol—Vomiting—Risedronate—osteoporosis	0.000176	0.000489	CcSEcCtD
Cilostazol—Rash—Risedronate—osteoporosis	0.000174	0.000485	CcSEcCtD
Cilostazol—Dermatitis—Risedronate—osteoporosis	0.000174	0.000484	CcSEcCtD
Cilostazol—Dizziness—Pamidronate—osteoporosis	0.000174	0.000483	CcSEcCtD
Cilostazol—Headache—Risedronate—osteoporosis	0.000173	0.000481	CcSEcCtD
Cilostazol—Asthenia—Zoledronate—osteoporosis	0.000172	0.000479	CcSEcCtD
Cilostazol—Pruritus—Zoledronate—osteoporosis	0.00017	0.000472	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000169	0.000469	CcSEcCtD
Cilostazol—Nausea—Ethinyl Estradiol—osteoporosis	0.000169	0.000468	CcSEcCtD
Cilostazol—Insomnia—Estradiol—osteoporosis	0.000167	0.000465	CcSEcCtD
Cilostazol—Vomiting—Pamidronate—osteoporosis	0.000167	0.000464	CcSEcCtD
Cilostazol—Paraesthesia—Estradiol—osteoporosis	0.000166	0.000462	CcSEcCtD
Cilostazol—Asthenia—Conjugated Estrogens—osteoporosis	0.000166	0.000461	CcSEcCtD
Cilostazol—Rash—Pamidronate—osteoporosis	0.000166	0.000461	CcSEcCtD
Cilostazol—Dermatitis—Pamidronate—osteoporosis	0.000166	0.00046	CcSEcCtD
Cilostazol—Dyspnoea—Estradiol—osteoporosis	0.000165	0.000458	CcSEcCtD
Cilostazol—Headache—Pamidronate—osteoporosis	0.000165	0.000458	CcSEcCtD
Cilostazol—Diarrhoea—Zoledronate—osteoporosis	0.000164	0.000457	CcSEcCtD
Cilostazol—Nausea—Risedronate—osteoporosis	0.000164	0.000456	CcSEcCtD
Cilostazol—Pruritus—Conjugated Estrogens—osteoporosis	0.000164	0.000455	CcSEcCtD
Cilostazol—Dyspepsia—Estradiol—osteoporosis	0.000163	0.000453	CcSEcCtD
Cilostazol—Decreased appetite—Estradiol—osteoporosis	0.000161	0.000447	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Estradiol—osteoporosis	0.00016	0.000444	CcSEcCtD
Cilostazol—Dizziness—Zoledronate—osteoporosis	0.000159	0.000441	CcSEcCtD
Cilostazol—Pain—Estradiol—osteoporosis	0.000158	0.00044	CcSEcCtD
Cilostazol—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000158	0.00044	CcSEcCtD
Cilostazol—Nausea—Pamidronate—osteoporosis	0.000156	0.000434	CcSEcCtD
Cilostazol—Dizziness—Conjugated Estrogens—osteoporosis	0.000153	0.000425	CcSEcCtD
Cilostazol—Vomiting—Zoledronate—osteoporosis	0.000153	0.000424	CcSEcCtD
Cilostazol—Feeling abnormal—Estradiol—osteoporosis	0.000153	0.000424	CcSEcCtD
Cilostazol—Rash—Zoledronate—osteoporosis	0.000151	0.000421	CcSEcCtD
Cilostazol—Gastrointestinal pain—Estradiol—osteoporosis	0.000151	0.000421	CcSEcCtD
Cilostazol—Dermatitis—Zoledronate—osteoporosis	0.000151	0.00042	CcSEcCtD
Cilostazol—Headache—Zoledronate—osteoporosis	0.000151	0.000418	CcSEcCtD
Cilostazol—Vomiting—Conjugated Estrogens—osteoporosis	0.000147	0.000409	CcSEcCtD
Cilostazol—Urticaria—Estradiol—osteoporosis	0.000147	0.000409	CcSEcCtD
Cilostazol—Body temperature increased—Estradiol—osteoporosis	0.000146	0.000407	CcSEcCtD
Cilostazol—Abdominal pain—Estradiol—osteoporosis	0.000146	0.000407	CcSEcCtD
Cilostazol—Rash—Conjugated Estrogens—osteoporosis	0.000146	0.000405	CcSEcCtD
Cilostazol—Dermatitis—Conjugated Estrogens—osteoporosis	0.000146	0.000405	CcSEcCtD
Cilostazol—Headache—Conjugated Estrogens—osteoporosis	0.000145	0.000403	CcSEcCtD
Cilostazol—Nausea—Zoledronate—osteoporosis	0.000143	0.000396	CcSEcCtD
Cilostazol—Nausea—Conjugated Estrogens—osteoporosis	0.000137	0.000382	CcSEcCtD
Cilostazol—Asthenia—Estradiol—osteoporosis	0.000133	0.000369	CcSEcCtD
Cilostazol—Pruritus—Estradiol—osteoporosis	0.000131	0.000364	CcSEcCtD
Cilostazol—Diarrhoea—Estradiol—osteoporosis	0.000127	0.000352	CcSEcCtD
Cilostazol—Dizziness—Estradiol—osteoporosis	0.000122	0.00034	CcSEcCtD
Cilostazol—Vomiting—Estradiol—osteoporosis	0.000118	0.000327	CcSEcCtD
Cilostazol—Rash—Estradiol—osteoporosis	0.000117	0.000324	CcSEcCtD
Cilostazol—Dermatitis—Estradiol—osteoporosis	0.000117	0.000324	CcSEcCtD
Cilostazol—Headache—Estradiol—osteoporosis	0.000116	0.000322	CcSEcCtD
Cilostazol—Nausea—Estradiol—osteoporosis	0.00011	0.000305	CcSEcCtD
Cilostazol—PDE3A—Signaling Pathways—PTH1R—osteoporosis	4.48e-05	0.00371	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—PTH—osteoporosis	4.39e-05	0.00364	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—CNR2—osteoporosis	4.28e-05	0.00355	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	4.14e-05	0.00343	CbGpPWpGaD
Cilostazol—CYP1A2—Biological oxidations—CYP27A1—osteoporosis	4.11e-05	0.0034	CbGpPWpGaD
Cilostazol—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	4.06e-05	0.00337	CbGpPWpGaD
Cilostazol—CYP3A5—Phase 1 - Functionalization of compounds—POMC—osteoporosis	4.05e-05	0.00336	CbGpPWpGaD
Cilostazol—CYP1A2—Metapathway biotransformation—CYP27A1—osteoporosis	4.05e-05	0.00336	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—PTH—osteoporosis	3.99e-05	0.0033	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—CNR2—osteoporosis	3.89e-05	0.00322	CbGpPWpGaD
Cilostazol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	3.87e-05	0.0032	CbGpPWpGaD
Cilostazol—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	3.87e-05	0.0032	CbGpPWpGaD
Cilostazol—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	3.82e-05	0.00316	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—WNT1—osteoporosis	3.65e-05	0.00303	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—PTHLH—osteoporosis	3.64e-05	0.00301	CbGpPWpGaD
Cilostazol—CYP3A5—Biological oxidations—CYP19A1—osteoporosis	3.58e-05	0.00297	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MGLL—osteoporosis	3.56e-05	0.00295	CbGpPWpGaD
Cilostazol—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	3.56e-05	0.00295	CbGpPWpGaD
Cilostazol—CYP3A5—Metapathway biotransformation—CYP19A1—osteoporosis	3.53e-05	0.00293	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	3.53e-05	0.00292	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—LRP5—osteoporosis	3.48e-05	0.00288	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	3.34e-05	0.00277	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—LRP6—osteoporosis	3.33e-05	0.00276	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—PTHLH—osteoporosis	3.3e-05	0.00274	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—CALCA—osteoporosis	3.2e-05	0.00265	CbGpPWpGaD
Cilostazol—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	3.17e-05	0.00263	CbGpPWpGaD
Cilostazol—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	3.14e-05	0.0026	CbGpPWpGaD
Cilostazol—CYP2C19—Phase 1 - Functionalization of compounds—POMC—osteoporosis	3.13e-05	0.0026	CbGpPWpGaD
Cilostazol—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	3.13e-05	0.00259	CbGpPWpGaD
Cilostazol—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	3.01e-05	0.00249	CbGpPWpGaD
Cilostazol—CYP3A7—Biological oxidations—POMC—osteoporosis	2.98e-05	0.00247	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—CALCA—osteoporosis	2.91e-05	0.00241	CbGpPWpGaD
Cilostazol—CYP2D6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.88e-05	0.00239	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PKM—osteoporosis	2.81e-05	0.00233	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—FDPS—osteoporosis	2.81e-05	0.00233	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—TLN1—osteoporosis	2.81e-05	0.00233	CbGpPWpGaD
Cilostazol—CYP2C19—Biological oxidations—CYP19A1—osteoporosis	2.77e-05	0.00229	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	2.76e-05	0.00229	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	2.75e-05	0.00228	CbGpPWpGaD
Cilostazol—CYP2C19—Metapathway biotransformation—CYP19A1—osteoporosis	2.73e-05	0.00226	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PGLS—osteoporosis	2.66e-05	0.00221	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GPD2—osteoporosis	2.66e-05	0.00221	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	2.6e-05	0.00216	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	2.6e-05	0.00215	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—IGF1—osteoporosis	2.55e-05	0.00211	CbGpPWpGaD
Cilostazol—CYP2D6—Biological oxidations—CYP19A1—osteoporosis	2.55e-05	0.00211	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	2.53e-05	0.0021	CbGpPWpGaD
Cilostazol—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	2.51e-05	0.00208	CbGpPWpGaD
Cilostazol—CYP1A2—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.44e-05	0.00202	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PNP—osteoporosis	2.44e-05	0.00202	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—ATIC—osteoporosis	2.44e-05	0.00202	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—P4HB—osteoporosis	2.42e-05	0.00201	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PTH—osteoporosis	2.36e-05	0.00195	CbGpPWpGaD
Cilostazol—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	2.32e-05	0.00193	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—RAP1A—osteoporosis	2.32e-05	0.00192	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CNR2—osteoporosis	2.3e-05	0.0019	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—ADCY5—osteoporosis	2.28e-05	0.00189	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—NFATC1—osteoporosis	2.26e-05	0.00187	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—DKK1—osteoporosis	2.24e-05	0.00186	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—WNT1—osteoporosis	2.16e-05	0.00179	CbGpPWpGaD
Cilostazol—CYP1A2—Biological oxidations—CYP19A1—osteoporosis	2.16e-05	0.00179	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	2.15e-05	0.00178	CbGpPWpGaD
Cilostazol—CYP3A5—Biological oxidations—POMC—osteoporosis	2.15e-05	0.00178	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	2.15e-05	0.00178	CbGpPWpGaD
Cilostazol—CYP1A2—Metapathway biotransformation—CYP19A1—osteoporosis	2.13e-05	0.00176	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—FGA—osteoporosis	2.1e-05	0.00174	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CA2—osteoporosis	2.07e-05	0.00172	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—OXCT1—osteoporosis	2.07e-05	0.00172	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—ADCY5—osteoporosis	2.07e-05	0.00171	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—FDPS—osteoporosis	2.03e-05	0.00168	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PKM—osteoporosis	2.03e-05	0.00168	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	2.03e-05	0.00168	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	2.02e-05	0.00168	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—MGLL—osteoporosis	2.02e-05	0.00167	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	2.01e-05	0.00166	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	2.01e-05	0.00166	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	1.97e-05	0.00163	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PTHLH—osteoporosis	1.95e-05	0.00162	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—BMP2—osteoporosis	1.95e-05	0.00162	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PGLS—osteoporosis	1.93e-05	0.00159	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GPD2—osteoporosis	1.93e-05	0.00159	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—FGB—osteoporosis	1.91e-05	0.00158	CbGpPWpGaD
Cilostazol—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.88e-05	0.00156	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PSMA2—osteoporosis	1.84e-05	0.00153	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PSMA5—osteoporosis	1.84e-05	0.00153	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ATIC—osteoporosis	1.76e-05	0.00146	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PNP—osteoporosis	1.76e-05	0.00146	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.72e-05	0.00143	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CALCA—osteoporosis	1.72e-05	0.00142	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—IDH2—osteoporosis	1.72e-05	0.00142	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—POMC—osteoporosis	1.68e-05	0.00139	CbGpPWpGaD
Cilostazol—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	1.67e-05	0.00138	CbGpPWpGaD
Cilostazol—CYP2C19—Biological oxidations—POMC—osteoporosis	1.66e-05	0.00138	CbGpPWpGaD
Cilostazol—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	1.64e-05	0.00136	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CYP27A1—osteoporosis	1.61e-05	0.00134	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.58e-05	0.00131	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PKM—osteoporosis	1.57e-05	0.0013	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—FDPS—osteoporosis	1.57e-05	0.0013	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—ACP5—osteoporosis	1.57e-05	0.0013	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—KL—osteoporosis	1.56e-05	0.00129	CbGpPWpGaD
Cilostazol—CYP2D6—Biological oxidations—POMC—osteoporosis	1.53e-05	0.00127	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—TGFB1—osteoporosis	1.53e-05	0.00127	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—POMC—osteoporosis	1.52e-05	0.00126	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—OXCT1—osteoporosis	1.5e-05	0.00124	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CA2—osteoporosis	1.5e-05	0.00124	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PGLS—osteoporosis	1.49e-05	0.00123	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GPD2—osteoporosis	1.49e-05	0.00123	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—IL6R—osteoporosis	1.48e-05	0.00123	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—TPI1—osteoporosis	1.46e-05	0.00121	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—MGLL—osteoporosis	1.46e-05	0.00121	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—FDPS—osteoporosis	1.44e-05	0.0012	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PKM—osteoporosis	1.44e-05	0.0012	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—P4HB—osteoporosis	1.37e-05	0.00114	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PGLS—osteoporosis	1.37e-05	0.00113	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GPD2—osteoporosis	1.37e-05	0.00113	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ATIC—osteoporosis	1.36e-05	0.00113	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PNP—osteoporosis	1.36e-05	0.00113	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GAPDH—osteoporosis	1.35e-05	0.00112	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.34e-05	0.00111	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—RAP1A—osteoporosis	1.31e-05	0.00109	CbGpPWpGaD
Cilostazol—CYP1A2—Biological oxidations—POMC—osteoporosis	1.3e-05	0.00107	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PNP—osteoporosis	1.25e-05	0.00104	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ATIC—osteoporosis	1.25e-05	0.00104	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—IDH2—osteoporosis	1.24e-05	0.00103	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PKM—osteoporosis	1.22e-05	0.00101	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—FDPS—osteoporosis	1.22e-05	0.00101	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—ADCY5—osteoporosis	1.22e-05	0.00101	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—SPP1—osteoporosis	1.18e-05	0.00098	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CYP27A1—osteoporosis	1.17e-05	0.000966	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PGLS—osteoporosis	1.16e-05	0.000961	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GPD2—osteoporosis	1.16e-05	0.000961	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CA2—osteoporosis	1.16e-05	0.000959	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—OXCT1—osteoporosis	1.16e-05	0.000959	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ACP5—osteoporosis	1.13e-05	0.00094	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—MGLL—osteoporosis	1.13e-05	0.000934	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—IRS2—osteoporosis	1.07e-05	0.000886	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CA2—osteoporosis	1.06e-05	0.000882	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—OXCT1—osteoporosis	1.06e-05	0.000882	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.06e-05	0.000881	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ATIC—osteoporosis	1.06e-05	0.000879	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PNP—osteoporosis	1.06e-05	0.000879	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—ENO1—osteoporosis	1.06e-05	0.000878	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—TPI1—osteoporosis	1.05e-05	0.000874	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—LEP—osteoporosis	1.05e-05	0.000867	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PSMA2—osteoporosis	1.04e-05	0.000865	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PSMA5—osteoporosis	1.04e-05	0.000865	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—MGLL—osteoporosis	1.04e-05	0.000859	CbGpPWpGaD
Cilostazol—CYP3A4—Biological oxidations—POMC—osteoporosis	1e-05	0.000829	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—ESR1—osteoporosis	9.99e-06	0.000828	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—P4HB—osteoporosis	9.92e-06	0.000822	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GAPDH—osteoporosis	9.73e-06	0.000806	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—IDH2—osteoporosis	9.59e-06	0.000794	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—RAP1A—osteoporosis	9.48e-06	0.000785	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—FDPS—osteoporosis	9.44e-06	0.000782	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PKM—osteoporosis	9.44e-06	0.000782	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—IRS1—osteoporosis	9.34e-06	0.000773	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—OXCT1—osteoporosis	9.02e-06	0.000747	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CA2—osteoporosis	9.02e-06	0.000747	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYP27A1—osteoporosis	9.02e-06	0.000747	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—POMC—osteoporosis	8.99e-06	0.000745	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GPD2—osteoporosis	8.95e-06	0.000741	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PGLS—osteoporosis	8.95e-06	0.000741	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—IDH2—osteoporosis	8.82e-06	0.000731	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—MGLL—osteoporosis	8.79e-06	0.000728	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ACP5—osteoporosis	8.77e-06	0.000727	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—IL6R—osteoporosis	8.77e-06	0.000727	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	8.66e-06	0.000717	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—IGF1—osteoporosis	8.65e-06	0.000716	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CYP19A1—osteoporosis	8.48e-06	0.000702	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP27A1—osteoporosis	8.29e-06	0.000687	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	8.29e-06	0.000686	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PNP—osteoporosis	8.19e-06	0.000678	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ATIC—osteoporosis	8.19e-06	0.000678	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—TPI1—osteoporosis	8.16e-06	0.000676	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ACP5—osteoporosis	8.07e-06	0.000668	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—P4HB—osteoporosis	7.67e-06	0.000635	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ENO1—osteoporosis	7.66e-06	0.000635	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PSMA2—osteoporosis	7.55e-06	0.000626	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PSMA5—osteoporosis	7.55e-06	0.000626	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GAPDH—osteoporosis	7.53e-06	0.000623	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—TPI1—osteoporosis	7.5e-06	0.000621	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—IDH2—osteoporosis	7.47e-06	0.000619	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—RAP1A—osteoporosis	7.33e-06	0.000607	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—P4HB—osteoporosis	7.05e-06	0.000584	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP27A1—osteoporosis	7.03e-06	0.000582	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CA2—osteoporosis	6.96e-06	0.000577	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—OXCT1—osteoporosis	6.96e-06	0.000577	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—ADCY5—osteoporosis	6.93e-06	0.000574	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GAPDH—osteoporosis	6.92e-06	0.000573	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GPX1—osteoporosis	6.9e-06	0.000572	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ACP5—osteoporosis	6.84e-06	0.000566	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—MGLL—osteoporosis	6.78e-06	0.000562	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	6.75e-06	0.000559	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—RAP1A—osteoporosis	6.74e-06	0.000558	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—IL6—osteoporosis	6.61e-06	0.000548	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	6.39e-06	0.000529	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—MTHFR—osteoporosis	6.37e-06	0.000528	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—TPI1—osteoporosis	6.35e-06	0.000526	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CYP19A1—osteoporosis	6.13e-06	0.000508	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—P4HB—osteoporosis	5.97e-06	0.000495	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ENO1—osteoporosis	5.93e-06	0.000491	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GAPDH—osteoporosis	5.86e-06	0.000486	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PSMA2—osteoporosis	5.84e-06	0.000484	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PSMA5—osteoporosis	5.84e-06	0.000484	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—IDH2—osteoporosis	5.77e-06	0.000478	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—RAP1A—osteoporosis	5.71e-06	0.000473	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ENO1—osteoporosis	5.45e-06	0.000451	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP27A1—osteoporosis	5.42e-06	0.000449	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PSMA2—osteoporosis	5.37e-06	0.000445	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PSMA5—osteoporosis	5.37e-06	0.000445	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ACP5—osteoporosis	5.28e-06	0.000437	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MYC—osteoporosis	5.2e-06	0.000431	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—TGFB1—osteoporosis	5.19e-06	0.00043	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—POMC—osteoporosis	5.09e-06	0.000422	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ADCY5—osteoporosis	5.01e-06	0.000415	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GPX1—osteoporosis	4.99e-06	0.000413	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.98e-06	0.000413	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—TPI1—osteoporosis	4.9e-06	0.000406	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYP19A1—osteoporosis	4.74e-06	0.000392	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ENO1—osteoporosis	4.62e-06	0.000382	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—P4HB—osteoporosis	4.61e-06	0.000382	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—MTHFR—osteoporosis	4.6e-06	0.000381	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PSMA2—osteoporosis	4.55e-06	0.000377	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PSMA5—osteoporosis	4.55e-06	0.000377	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GAPDH—osteoporosis	4.53e-06	0.000375	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—RAP1A—osteoporosis	4.41e-06	0.000365	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP19A1—osteoporosis	4.36e-06	0.000361	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—IL6—osteoporosis	3.91e-06	0.000324	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ADCY5—osteoporosis	3.87e-06	0.000321	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GPX1—osteoporosis	3.86e-06	0.000319	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP19A1—osteoporosis	3.69e-06	0.000306	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—POMC—osteoporosis	3.68e-06	0.000305	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ENO1—osteoporosis	3.56e-06	0.000295	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ADCY5—osteoporosis	3.56e-06	0.000295	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—MTHFR—osteoporosis	3.56e-06	0.000295	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GPX1—osteoporosis	3.55e-06	0.000294	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PSMA2—osteoporosis	3.51e-06	0.000291	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PSMA5—osteoporosis	3.51e-06	0.000291	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—MTHFR—osteoporosis	3.27e-06	0.000271	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ADCY5—osteoporosis	3.02e-06	0.00025	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GPX1—osteoporosis	3.01e-06	0.000249	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP19A1—osteoporosis	2.85e-06	0.000236	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—POMC—osteoporosis	2.85e-06	0.000236	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—MTHFR—osteoporosis	2.77e-06	0.00023	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—POMC—osteoporosis	2.62e-06	0.000217	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ADCY5—osteoporosis	2.33e-06	0.000193	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GPX1—osteoporosis	2.32e-06	0.000192	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—POMC—osteoporosis	2.22e-06	0.000184	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—MTHFR—osteoporosis	2.14e-06	0.000177	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—POMC—osteoporosis	1.71e-06	0.000142	CbGpPWpGaD
